SynthesisBMC cancer2017
Pooled safety analyses of ALK-TKI inhibitor in ALK-positive NSCLC.
Qian Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papertrialcites it
SynthesisBMC cancer2017
Qian Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.